SEC 13F Intelligence

Managers / Q2 2022 · view latest →

Duquesne Family Office LLC

CIK 0001536411 · Part of the Duquesne family · 40 WEST 57TH STREET, 25TH FLOOR, NEW YORK, NY, 10019 · (212) 830-6500

Reported Value
$1.4B
Q2 2022
Positions
43
Filings on Record
32
2019–present window
Filed
Aug 15, 2022
original filing

Summary

Duquesne Family Office LLC reported $1.4B in U.S.-listed holdings across 43 positions for Q2 2022.

Its largest position, CPNG, represents 17.9% of the portfolio.

Compared with Q1 2022, the fund opened 9 new positions and exited 17.

Portfolio Metrics

Turnover
+15.3%
vs prior filed quarter
Top-10 Concentration
+75.1%
share of reported value
Largest Position
+17.9%
Coupang
New / Exited
9 / 17
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.7BQ4 ’18Q1 ’19: $3.4BQ2 ’19: $3.4BQ3 ’19: $2.6BQ4 ’19: $3.4BQ4 ’19Q1 ’20: $2.5BQ2 ’20: $3.3BQ3 ’20: $3.4BQ4 ’20: $3.7BQ4 ’20Q1 ’21: $4.5BQ2 ’21: $4.0BQ3 ’21: $3.1BQ4 ’21: $2.8BQ4 ’21Q1 ’22: $2.3BQ2 ’22: $1.4BQ3 ’22: $1.8BQ4 ’22: $2.0BQ4 ’22Q1 ’23: $2.3BQ2 ’23: $2.9BQ3 ’23: $2.8BQ4 ’23: $3.4BQ4 ’23Q1 ’24: $4.4BQ2 ’24: $2.9BQ3 ’24: $3.0BQ4 ’24: $3.7BQ4 ’24Q1 ’25: $3.1BQ2 ’25: $4.1BQ3 ’25: $4.1BQ4 ’25: $4.5BQ4 ’25Q1 ’26: $3.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 99.5%Other: 0.5%
  • Common Stock · 99.5% · $1.4B
  • Other · 0.5% · $7M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
LLYLilly Eli & CoNEW+297.1K297.1K+$96M$96M
CRWDCrowdstrike Hldgs IncNEW+229.6K229.6K+$39M$39M
MRNAModerna IncNEW+207.7K207.7K+$30M$30M
DDOGDatadog IncNEW+298.0K298.0K+$28M$28M
PANWPalo Alto Networks IncNEW+51.4K51.4K+$25M$25M
EIXEdison IntlNEW+287.6K287.6K+$18M$18M
WLKWestlake CorporationNEW+145.5K145.5K+$14M$14M
EQTEqt CorpNEW+259.1K259.1K+$9M$9M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

42 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CPNGCoupang Inchistory →CL A17.93%$248M19.43M
2MSFTMicrosoft Corphistory →COM13.77%$190M740.8K
3CVXChevron Corp Newhistory →COM8.70%$120M830.4K
4LLYLilly Eli & Cohistory →COM6.97%$96M297.1K
5FCXFreeport-Mcmoran Inchistory →CL B6.84%$95M3.23M
6TMUST-Mobile Us Inchistory →COM6.59%$91M676.9K
7KBRKbr Inchistory →COM4.57%$63M1.30M
8WSCWillscot Mobil Mini Hldng Cohistory →COM CL A4.15%$57M1.77M
9CRWDCrowdstrike Hldgs Inchistory →CL A2.80%$39M229.6K
10PLTRPalantir Technologies Inchistory →CL A2.79%$39M4.26M
11CTRACoterra Energy Inchistory →COM2.59%$36M1.39M
12TECKTeck Resources Ltdhistory →CL B2.35%$32M1.06M
13ARAntero Resources Corphistory →COM2.26%$31M1.02M
14MRNAModerna Inchistory →COM2.15%$30M207.7K
15DDOGDatadog Inchistory →CL A COM2.05%$28M298.0K
16PANWPalo Alto Networks Inchistory →COM1.84%$25M51.4K
17CVECenovus Energy Inchistory →COM1.47%$20M1.07M
18EIXEdison Intlhistory →COM1.32%$18M287.6K
19WLKWestlake Corporationhistory →COM1.03%$14M145.5K
20BKNGBooking Holdings Inchistory →COM0.98%$14M7.7K
21WDAYWorkday Inchistory →CL A0.83%$12M82.5K
22Pioneer Nat Res CoCOM0.78%$11M48.5K
23PSXPhillips 66history →COM0.71%$10M119.4K
24EQTEqt Corphistory →COM0.64%$9M259.1K
25ABCLAbcellera Biologics Inchistory →COM0.51%$7M659.8K
26Ihs Holding LimitedORD SHS0.47%$6M771.1K
27Smartsheet IncCOM CL A0.34%$5M149.8K
28IOTSamsara Inchistory →COM CL A0.32%$4M400.9K
29OSCROscar Health Inchistory →CL A0.31%$4M994.3K
30SEDGSolaredge Technologies Inchistory →COM0.27%$4M13.4K
31CCCCcc Intelligent Solutions Hlhistory →COM0.19%$3M281.9K
32RXRXRecursion Pharmaceuticals Inhistory →CL A0.16%$2M273.6K
33DISHDish Network Corporationhistory →CL A0.15%$2M112.4K
34Reata Pharmaceuticals IncCL A0.13%$2M59.0K
35CRBUCaribou Biosciences Inchistory →COM0.11%$1M271.4K
36COMPCompass Inchistory →CL A0.10%$1M399.1K
37PRCTProcept Biorobotics Corphistory →COM0.09%$1M39.3K
38OPENOpendoor Technologies Inchistory →COM0.08%$1M233.0K
39ACADAcadia Pharmaceuticals Inchistory →COM0.08%$1M74.4K
40Global E Online LtdSHS0.03%$407,00020.2K
41Sensei Biotherapeutics IncCOM0.02%$227,000100.0K
42Cazoo Group LtdCOM0.01%$101,000140.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.4B70May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$4.5B62Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$4.1B65Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$4.1B69Aug 15, 202513F-HRchanges · EDGAR ↗
Q1 2025$3.1B52May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$3.7B78Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$3.0B75Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.9B64Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$4.4B73May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$3.4B51Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.8B41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.9B53Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.3B48May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.0B58Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.8B65Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.3B51May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.8B49Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.1B49Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$4.0B52Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021REVEALED$4.5B64May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.7B56Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$3.4B61Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B72Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.5B46May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.4B62Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.6B43Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.4B61Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.4B61May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.7B31Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.